CLINICAL TRIALS PROFILE FOR TIMENTIN
✉ Email this page to a colleague
All Clinical Trials for TIMENTIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02158442 ↗ | Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients | Completed | Osprey Medical, Inc | Phase 2 | 2013-10-01 | The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TIMENTIN
Condition Name
Clinical Trial Locations for TIMENTIN
Clinical Trial Progress for TIMENTIN
Clinical Trial Phase
Clinical Trial Sponsors for TIMENTIN
Sponsor Name